Theme: “comprehensive overview of what personalized Medicine means today”

Personalized Medicine 2017

Renowned Speakers

Personalized Medicine 2017

Sessions and Tracks

About conference:

The 7th International conference on Predictive Preventive and PersonalizedMedicine & Molecular Diagnostics will be held on October 23-25, 2017 at Chicago, USA will be organized around the theme comprehensive overview of what personalized Medicine means today”  which comprises 17 Sessions/Tracks to outline the theme of the conference organized by ConferenceseriesLLC. The main aim of the conference is to highlight the achievements and innovations in the various fields of Personalized Medicine across the globe.

Tracks: 1 Paths of Biomarkers

In medication, a biomarker and sub-atomic markers are the quantifiable pointer of the seriousness or vicinity of some infection state. All the more by and large a biomarker is anything that can be utilized as a marker of a specific ailment state or some other physiological condition of a living being Drug-Diagnostic Co-Development. In the present period of stratified solution and biomarker-driven treatments, the centre has moved from forecasts taking into account the conventional anatomic arranging frameworks to direct the decision of treatment for an individual patient to a coordinated methodology utilizing the hereditary cosmetics of the tumour and the genotype of the patient. Genomics and other innovations have to a great extent added to the recognizable proof and the improvement of biomarkers such as Stratification biomarkers in customized pharmaceutical.

Relevant conferences:

5th European Predictive, Preventive & Personalized Medicine & Molecular Diagnostics December 01-02, 2016 Valencia, Spain; 2nd Cancer Diagnostics Conference & Expo May 8-10, 2017 Barcelona, Spain; 4th  International Conference on Clinical Trials September 11-13, 2017 San Antonio, USA; 9th  International Conference on Genomics and Pharmacogenomics June 15-16, 2017 London, UK;  2nd  World Congress on Molecular Genetics and Gene Therapy  July 3-5, 2017 Bangkok, Thailand; Quantitative Genetics & Genomics  February 26 - March 3, 2017 Galveston, TX; Personalizing Cancer Medicine Conference  2017 February 6-7, 2017. Courtyard by Marriott Downtown Toronto.      

Track 2: Clinical Case Reports: Genetics

Customized solution depends on interspecies contrasts. It is proverbial that little contrasts in hereditary make-up can bring about emotional contrasts because of medications or ailment and societal effect of customized pharmaceutical. To express this in more broad terms in any given complex framework, little changes in beginning conditions can bring about drastically diverse results. In spite of human variability and interspecies variety in different species, nonhuman species are still the essential model for finding out information for personalized solution wellbeing change in Human.

Relevant conferences:

5th European Conference on Clinical and Medical Case Reports September 07-08, 2017 Paris, France; 6th Global Experts Meeting on Medical Case Reports October 16-18, 2017 San Francisco, California, USA; 4th International Conference on Clinical Case Reports April 17-19, 2017 Dubai, UAE; Precision Medicine and Personalized Medicine December 1-2, 2016 San Antonio, USA; Precision Medicine World Conference (PMWC) 2017  January 23-25, 2017 Silicon Valley; Individualizing Medicine conference 2017 October 09-11, 2017 Rochester, Minnesota.

Track 3:  Life Style Medicine

Life Medicine (LM) is the utilization of way of life mediations in the treatment and administration of infection. LM is turning into the favoured methodology for the counteractive action as well as the treatment of most perpetual sicknesses, including Type-2 Diabetes, Coronary Heart Disease, Hypertension, Obesity, Insulin Resistance Syndrome, Osteoporosis, malignancy prevention. Likewise incorporate Aerobic and Resistance practices for patients with diabetes, Sleep and infection counteractive action, intrinsic inspiration and wellbeing conduct adherence.

Relevant conferences:

4thInternational Conference and Exhibition on Pain Medicine  August 03-04, 2017 San Francisco, USA; 2nd International Conference on Cardiovascular Medicine March 15-16, 2017 London, UK;14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA;19th Annual Cardiology Congress August 31-September 01, 2017 Philadelphia, USA; 18th  Global Cardiologists Conference June 19-21, 2017 Paris, France; 5th European Predictive, Preventive & Personalized Medicine & Molecular Diagnostics December 01-02, 2016 Valencia, Spain; Personalizing Cancer Medicine Conference  2017 February 6-7, 2017. Courtyard by Marriott Downtown Toronto.

Track 4: Preventive Medicine

Preventive Medicine is honed by all doctors to keep their patients sound. It is additionally an exceptional medicinal claim to fame perceived by the American Board of Medical Specialties (ABMS). Preventive Medicine concentrates on the wellbeing of people, groups, and characterized populaces. It is likewise utilized for the treatment for stoutness, visual impairment. The Epidemiology Division applies research strategies to comprehend the examples and reasons for wellbeing and ailment in the populace and to make an interpretation of this learning into projects intended to avert malady. The division has a long history of inclusion in NIH-supported multi-site, longitudinal partner studies, and its personnel manage numerous specialist started, NIH-supported exploration ventures and trials.

Relevant conferences:

5th European Predictive, Preventive & Personalized Medicine & Molecular Diagnostics December 01-02, 2016 Valencia, 2nd International Conference on Internal Medicine Sep 14-15, 2017 Dallas, USA; 7th International Conference on Tissue Engineering & Regenerative Medicine October 02-04, 2017 Barcelona, Spain; 4th  International Conference and Exhibition on Pain Medicine August 03-04, 2017 San Francisco, USA; 4th  International Conference on Clinical Trials September 11-13, 2017 San Antonio, USA.

Track 5: Personalized Medicine & its Innovation

Personalized Medicine is a developing routine of medication that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, determination, and treatment of ailment. Information of a patient's hereditary profile can offer specialists some assistance with selecting the best possible prescription or treatment and manage it utilizing the correct measurement or regimen. Utilized for the treatment as Personalized growth solution, Diabetes-related sickness: hazard appraisal and administration, Personalized pharmaceutical: New procedures and monetary ramifications, Implications of customized prescription in treatment of HIV, Applications of customized drug in uncommon illnesses, Translational Medicine.

Relevant conferences :

5th European Predictive, Preventive & Personalized Medicine & Molecular Diagnostics December 01-02, 2016 Valencia, Spain; International Conference on Precision Medicine and Personalized Medicine December 1-2, 2016 San Antonio, USA; 5th European Conference on Clinical and Medical Case Reports September 07-08, 2017 Paris, France; Individualizing Medicine conference 2017 October 09-11, 2017 Rochester, Minnesota; Precision Medicine World Conference  2017 January 23-25, 2017 Silicon Valley; Personalizing Cancer Medicine Conference 2017 February 6-7, 2017. Courtyard by Marriott Downtown Toronto.

Track 6: Advances in Molecular Diagnostics

Personalized Medicine is a developing routine of medication that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, determination, and treatment of ailment. Information of a patient's hereditary profile can offer specialists some assistance with selecting the best possible prescription or treatment and manage it utilizing the correct measurement or regimen. Utilized for the treatment as Personalized growth solution, Diabetes-related sickness: hazard appraisal and administration, Personalized pharmaceutical: New procedures and monetary ramifications, Implications of customized prescription in treatment of HIV, Applications of customized drug in uncommon illnesses, Translational Medicine.

Relevant conferences

6th European Predictive, Preventive & Personalized Medicine & Molecular Diagnostics August 23-24, 2017 Birmingham, UK; 2nd Cancer Diagnostics Conference & Expo May 8-10, 2017 Barcelona, Spain; Individualizing Medicine conference 2017 October 09-11, 2017 Rochester, Minnesota; Quantitative Genetics & Genomics  February 26 - March 3, 2017 Galveston, TX.

Track 7: Market Strategies & Challenges In Personalised Medicine

P4 Medicine is an arrangement to profoundly enhance the nature of human life by means of biotechnology. P4 Medicine is a term authored by scholar Leroy Hood, and is another way to say "Predictive, Preventive, Personalized Medicine, and Molecular Medicine." The reason of P4 Medicine is that, throughout the following 20 years, restorative practice will be altered by biotechnology, to deal with a man's wellbeing, rather than deal with a patient's infection. Inner solution or general medication (in Commonwealth countries) is the medicinal claim to fame managing the avoidance, determination, and treatment of grown-up maladies. Crisis solution is a medicinal claim to fame including watch over grown-up and paediatric patients with intense sicknesses or wounds that require quick therapeutic consideration.

Relevant conferences:

International Conference on Precision Medicine and Personalized Medicine December 1-2, 2016 San Antonio, USA; 5th International Conference on HIV/AIDS, STDs and STIs November 13-14, 2017 Las Vegas, Nevada, USA; 4th International Conference on Clinical Case Reports April 17-19, 2017 Dubai, UAE; World Congress on Breast Pathology August 24-25, 2017 Toronto, Canada; 13th European Pathology Congress Aug 02-03, 2017 Milan, Italy; 14th International Conference on Oral and Maxilofacial Pathology September 18-20, 2017 Jackson Ville, USA.

Track 9: Novelty in Personalised Medicine

Personalized Medicine is a developing routine of prescription that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, analysis, and treatment of malady. Learning of a patient's hereditary profile can offer specialists some assistance with selecting the correct prescription or treatment and control it utilizing the best possible measurements or regimen. Utilized for the treatment as Personalized malignancy pharmaceutical, Diabetes-related sickness: hazard evaluation and administration, Personalized drug: New procedures and monetary ramifications, Implications of customized medication in treatment of HIV, Applications of customized prescription in uncommon infections, Translational Medicine.

Relevant Conferences:

9th International Conference on Genomics and Pharmacogenomics;   International Conference on Epigenetics  2017 November 13-15, 2017 Frankfurt, Germany; 2nd International Conference on Cardiovascular Medicine March 15-16, 2017 London, UK;  14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA; 19th Annual Cardiology Congress August 31-September 01, 2017 Philadelphia, USA.

Track 10: Genomics & Personalized Medicine

Genomics is a control in hereditary qualities that applies Recombinant DNA, DNA sequencing techniques, and bioinformatics to grouping, amass, and break down the capacity and structure of genomes. Propels in genomics have set off an insurgency in disclosure based examination to see even the most complex organic frameworks, for example, the mind. The field incorporates endeavours to decide the whole DNA grouping and human genome variation of life forms and fine-scale hereditary mapping. The field additionally incorporates investigations of intragenomic marvels, for example, heterosis, epistasis, pleiotropy and different associations in the middle of loci and all within the genome and met genomics.

Relevant conferences:

International Conference on Precision Medicine and Personalized Medicine December 1-2, 2016 San Antonio, USA; 5th International Conference on HIV/AIDS, STDs and STIs November 13-14, 2017 Las Vegas, Nevada, USA; 9th International Conference on Genomics and Pharmacogenomics June 15-16, 2017 London, UK;   2nd World Congress on Human Genetics & Genetic Disorders November 02-03, 2017 Toronto, Canada; 2nd World Congress on Molecular Genetics and Gene Therapy July 3-5, 2017 Bangkok, Thailand; 4th International Conference and Exhibition on Pain Medicine August 03-04, 2017 San Francisco, USA.

Track 11: Genetics of Ebola Outbreak

Arrangement investigation of Ebola infection Genome is the second through the 6th qualities of the Ebola infection (EBO) genome demonstrates that it is sorted out also to rhabdoviruses and paramyxoviruses and is for all intents and purposes the same as Marburg infection (MBG). Researchers utilized genomic sequencing advancements to recognize the starting point and track transmission of the Ebola infection in the ebb and flow flare-up in Africa.

Relevant conferences:

2nd World Congress on Human Genetics & Genetic Disorders November 02-03, 2017 Toronto, Canada; 9thInternational Conference on Genomics and Pharmacogenomics June 15-16, 2017 London, UK; 8th International Conference and Exhibition on Metabolomics May 11-13, 2017 Singapore; 9th  World Congress on Pharmacology August 07-09, 2017 Paris, France; 2nd Cancer Diagnostics Conference & Expo May 8-10, 2017 Barcelona, Spain; Individualizing Medicine conference 2017 October 09-11, 2017 Rochester, Minnesota; Quantitative Genetics & Genomics  February 26 - March 3, 2017 Galveston, TX.

Track 12: Approaches To Stem Cells

Personalized Medicine can be utilized to find out around a man's hereditary cosmetics and to disentangle the science of their tumour. Utilizing this data, specialists want to recognize anticipation, screening, and treatment techniques that might be more successful and cause less symptoms than would be normal with standard medicines. By performing more hereditary tests and examination, specialists might alter treatment to every patient's needs. Making a customized malignancy screening and treatment arrangement incorporates: Determining the odds that a man will create growth and selecting screening techniques to bring down the danger, Matching patients with medications that will probably be compelling and cause less reactions, Predicting the danger of repeat (return of Cancer)

Relevant conferences:

9th Annual Conference on Stem Cell and Regenerative Medicine Sep 25-26, 2017 Berlin, Germany; 8th World Congress and Expo on Cell & Stem Cell Research March 20-22, 2017 Orlando, Florida, USA; 4th International Conference on Clinical Case Reports April 17-19, 2017 Dubai, UAE; World Congress on Breast Pathology August 24-25, 2017 Toronto, Canada; 13th European Pathology Congress Aug 02-03, 2017 Milan, Italy; 14th International Conference on Oral and Maxilofacial Pathology September 18-20, 2017 Jackson Ville, USA.

Track 13: Nanotechnology: Future of Personalised Medicine

Nanotechnology ("nanotech") is the control of matter on a nuclear, atomic, and supramolecular scale. The soonest, across the board portrayal of nanotechnology alluded to the specific mechanical objective of accurately controlling particles and atoms for creation of macro scale items, likewise now alluded to as sub-atomic nanotechnology. Uses of pharmaceutical Nano tools, Cell based treatment Molecular systems are the strategies and instrument in Nano innovation and biotechnology.

Relevant conferences:

9th International Conference on Genomics and Pharmacogenomics June 15-16, 2017 London, UK;   2nd World Congress on Human Genetics & Genetic Disorders November 02-03, 2017 Toronto, Canada; 2nd World Congress on Molecular Genetics and Gene Therapy July 3-5, 2017 Bangkok, Thailand; 4th International Conference and Exhibition on Pain Medicine August 03-04, 2017 San Francisco, USA; 7th International Conference on Tissue Engineering & Regenerative Medicine October 02-04, 2017 Barcelona, Spain; Personalizing Cancer Medicine Conference 2017 February 6-7, 2017.Courtyard by Marriott Downtown Toronto. 

Track 14: Personalized Drug Therapy

Personalized  drug is a field of medication that involves foreseeing the likelihood of malady and establishing preventive measures keeping in mind the end goal to either keep the ailment by and large or altogether abatement its effect upon the patient, (for example, by avoiding mortality or constraining dreariness). Methods and measures incorporate New-born screening, Diagnostic testing, Medical bioinformatics, Prenatal testing, Carrier testing, Preconception testing. Infant screening is a general wellbeing program intended to screen babies not long after conception for a rundown of conditions that are treatable, however not clinically clear in the infant period. Pre-birth testing: Prenatal testing is utilized to search for sicknesses and conditions in a hatchling or developing life before it is conceived. This kind of testing is offered for couples who have an expanded danger of having a child with a hereditary or chromosomal issue.

Relevant conferences:

9th International Conference on Genomics and Pharmacogenomics;   International Conference on Epigenetics  2017 November 13-15, 2017 Frankfurt, Germany; 2nd International Conference on Cardiovascular Medicine March 15-16, 2017 London, UK; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA; 19th Annual Cardiology Congress August 31-September 01, 2017 Philadelphia, USA.

Track 15: Personalized Oncology

The era of personalized oncology medicine has the potential to fulfil the promise of delivering the right dose for the right indication to the right patient at the right time. Imagine your oncologist knowing before he makes a treatment decision how well your cancer may respond to a particular therapy. Tools that enable a more informed treatment decision do exist and may help individualize your cancer care. It is very important for oncologists to keep updated of the latest advancements in oncology as changes in management of cancer are quite common. All fit patients whose cancer progresses and no standard of care treatment options are available should be enrolled in a clinical trial. Personalized medicine is used to learn about a person’s genetic makeup and how their tumor grows. Using this data, doctors hope to find prevention, screening, and treatment strategies that may be more effective. They also want to find ones that cause fewer side effects than the standard treatments. By performing more genetic tests, doctors may customize treatment to each patient’s needs.

Relevant conferences:

2ndCancer Diagnostics Conference & Expo May 8-10, 2017 Barcelona, Spain; Cancer Genetics & Epigenetics April 23-28, 2017 Lucca, Italy; International Conference on Precision Medicine and Personalized Medicine December 1-2, 2016 San Antonio, USA; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; Individualizing Medicine conference 2017 October 09-11, 2017 Rochester, Minnesota; Personalizing Cancer Medicine Conference 2017 February 6-7, 2017. Courtyard by Marriott Downtown Toronto; Cancer Genetics & Epigenetics April 23-28, 2017 Lucca, Italy.

Track 16: Immunology Infectious Disease

Clinical immunology is the study of diseases caused by disorders of the immune system. It also involves diseases of other systems, where immune reactions play a part in the pathology and clinical features. Many components of the immune system are actually cellular in nature and not associated with any specific organ but rather are embedded or circulating in various tissues located throughout the body. Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Because of the immune system's unique properties, these therapies may hold greater potential than current treatment approaches to fight cancer more powerfully, to offer longer-term protection against the disease, to come with fewer side effects, and to benefit more patients with more cancer types. Scientists believe that for most people, Alzheimer's disease results from a combination of genetic, lifestyle and environmental factors that affect the brain over time. In Parkinson’s disease, cells that produce dopamine start to die. Dopamine is a chemical that helps you move normally. There is no known direct cause of Parkinson’s. One theory is that it may be hereditary. Other theories say exposure to pesticides and living in rural communities may cause it.

Relevant conferences:

2nd International Conference on Parkinson’s disease & Movement Disorders  December 05-07, 2016 Phoenix, USA; 1st Pan American Parkinson’s Disease and Movement Disorders Congress; 4th International congress on Infectious Diseases May 11-12, 2017 Barcelona, Spain; 5th  International Congress on Bacteriology and Infectious Diseases May 25-26, 2017 Chicago, Illinois, USA; 5th  World Congress on Infectious Diseases  August 21-23, 2017 San Francisco, California, USA;7th International Conference on Alzheimer’s Disease & Dementia October 16-18, 2017 Rome, Italy.

Track 17: Cardiology and Vascular Medicine

The objective of the Cardiac Research is to quicken interpretation of promising new crucial examination revelations for the treatment of heart disappointment and arrhythmias through very much composed clinical trials that exhibit viability and security. Vascular Medicine envelops a wide range of different disease states. As the field of vascular Medicine develops, the extent of illnesses being dealt with changes. Cardiovascular renovating alludes to the adjustments in size, shape, structure and physiology of the heart after damage to the myocardium. The harm is normally because of intense myocardial dead tissue. To portray the expansion in lipoprotein interpretation by hypothyroidism, adipocytes were readied from control and hypothyroid rats. While LPL combination was higher in hypothyroid adipocytes, with no adjustment in mRNA levels, there was no expansion in hormone-touchy lipase (HSL) blend.

To figure out if an executing interpretation administrative component was available, a cytoplasmic portion was readied from control and hypothyroid adipocytes, and added to an in vitro interpretation framework containing the hLPL mRNA. Clinical results with non-biologic treatment, given ahead of schedule over the span of the ailment, are in the same class as with biologic treatments. Mixes of medicines are normally required to accomplish quick and supported reduction.

Relevant conferences:

2nd International Conference on Cardiovascular Medicine March 15-16, 2017 London, UK;14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA; 19th Annual Cardiology Congress August 31-September 01, 2017 Philadelphia, USA; 4th  International Conference and Exhibition on Pain Medicine August 03-04, 2017 San Francisco, USA; 4th  International Conference on Clinical Trials September 11-13, 2017 San Antonio, USA.





About Conference

Personalized medicine 2017 invites scholars, researchers, academicians, students and corporate entities across the globe to join at the 7th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics (Personalized medicine-2017) to have a meaningful discussion with scholars during October 23-25,2017 in Chicago,USA. The conference focuses on comprehensive overview of what personalized Medicine means today” .

Personalized medicine 2016 anticipates more than 300 participants around the globe with thought provoking Keynote lectures, Oral, Young Researcher Forum and Poster presentations with Exhibition. The attending delegates include Editorial Board Members of related Journals.

After Successful completion of personalized medicine 2016, Conference Series LLC welcomes all to join the exclusive event 4th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics, Phoenix, USA and showcase the recent research in the tremendous field of personalized medicine among the experts.

Students are warmly welcome to attend or to present their research work as Poster presenter and Young Researcher forum in this prestigious profile Personalized medicine.

Who is Attending?

  • Deans/Chairs, Vice Deans & Vice Presidents of Medical Institutions and Hospitals
  • Professors and students from academia who are in the field of research, Medical and clinical research.
  • Physicians, Business delegates, Directors / Managers & Business Intelligence Experts, Departmental Managers.

Benefits of Attending the Conference

  • The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows, Certificate Accreditation from the Organizing Committee of presentation/ participation.
  • Accepted Abstracts will be published in the respective journals and will be labeled with a Digital Object Identification Number (DOI) provided by Cross Ref (Free abstract publishing).
  • Speaker and Abstract pages created in Google on your name would get worldwide acknowledgment to your profile and Research.
  • Best Poster and Young Researcher Award.

Supporting Journals:

 

Contact Person:

Max Steven

Program Manager | Personalized medicine 2017

Phone: 1-888-843-8169

Email: Personalizedmedicine@conferencesereis.net




 





Market Analysis

Importance and Scope:

Personalized Medicine is an affecting learning method around a man's hereditary cosmetics and to unwind the science of their growth. Utilizing this data, specialists plan to distinguish counteractive action, screening, and treatment systems that might be more successful and cause less symptoms than would be normal with standard medications. By performing more hereditary tests and examination, specialists might modify treatment to every patient's needs

Personalized Cancer Medicine and treatments: Deciding the odds that a man will create disease and selecting screening procedures to bring down the danger, Matching patients with medications that will probably be powerful and cause less reactions, Predicting the danger of repeat (return of cancer).It is a developing field of pharmaceutical in which medicines are customized to the individual patient. Customized Diagnostics are medicinal gadgets that offer specialists some assistance with deciding which medications to offer patients and which measurements to give, custom-made particularly to the patient, says Elizabeth A. Mansfield, Ph.D., Deputy Office Director for Personalized Medicine in FDA's Office of In Vitro Diagnostics and Radiological Health. The friend analytic is fundamental to the sheltered and compelling utilization of the medication.

Personalized Medicine Diabetes is the utilization of data about the hereditary cosmetics of a man with diabetes to modify strategies for anticipating, recognizing, treating, or observing their diabetes. The act of PMFD includes four procedures. Initially is the ID of qualities and biomarkers for diabetes and additionally for corpulence. Second, is designation of assets to anticipate or recognize the diabetes and/or weight phenotype in high-hazard people, whose danger depends on their genotype. Third is determination of individualized treatments for influenced people. Fourth is estimation of flowing biomarkers of diabetes to screen the reaction to counteractive action or treatment.

Personalized Medicine World Conference  will serve as a drive for the progression of sub-atomic investigation by associating researchers the whole way across the world at gatherings and presentations that would make a situation helpful for data trade, era of new thoughts and speeding up of uses. Customized Medicine Conference guarantees numerous restorative advancements, and can possibly change the way medications are found and utilized.

Cancer chemotherapy is in advancement from non-particular cytotoxic medications that harm both tumour and typical cells to more particular specialists and immunotherapy approaches Targeted operators are coordinated at one of a kind sub-atomic components of growth cells, and resistant therapeutics regulate the tumour insusceptible reaction; both methodologies plan to create more prominent viability with less danger. The advancement and utilization of such operators in biomarker-characterized populaces empowers a more Personalized Medicine Oncology treatment than already conceivable and can possibly lessen the expense of disease consideration.

The expression "Personalized medicine" is regularly depicted as giving "the right patient with the right medication at the right dosage at the correct time." More comprehensively, customized solution (otherwise called accuracy prescription) might be considered as the customizing of medicinal treatment to the individual qualities, needs, and inclinations of a patient amid all phases of consideration, including counteractive action, conclusion, treatment, and postliminary. Worldwide mastery Gathering on Personalized Medicine World Congress.

Personalized Medicine will move therapeutic practices upstream from the responsive treatment of infection, to proactive social insurance administration including screening, early treatment, and counteractive action, and will adjust the parts of both doctor and patient. Customized pharmaceutical requires a frameworks way to deal with usage. Be that as it may, in a social insurance economy that is profoundly decentralized and advertise driven, it is occupant upon the partners themselves to advocate for a steady arrangement of approaches and enactment that make ready for the reception of customized prescription. To address this need, the Personalized Medicine Coalition (PMC) was shaped as a non-benefit umbrella association of pharmaceutical, biotechnology, demonstrative, and data innovation organizations, social insurance suppliers and payers, understanding backing bunches, industry approach associations, real scholastic foundations, and government offices.

Pharmacogenomics is a piece of a field called customized solution, additionally called individualized or exactness pharmaceutical that means to redo medicinal services, with choices and medications custom-made to every individual patient inside and out conceivable. Despite the fact that genomic testing is still a generally new improvement in medication treatment, this field is extending. At present, more than 100 medications have name data with respect to Personalized Medicine Pharmacogenomics biomarkers: some quantifiable or identifiable fragment of hereditary data that can be utilized to coordinate the utilization of a medication.

Propels in human genome examination are opening the way to another worldview for honing solution that guarantees to change social insurance. Customized solution, the utilization of marker-helped conclusion and focused on treatments got from an individual's atomic profile, will affect the way medications are created and pharmaceutical is honed. The customary straight procedure of medication disclosure and improvement will be supplanted by an incorporated and heuristic methodology. What's more, Personalized Medicine Patient Care will be altered using novel atomic inclination, screening, analytic, prognostic, pharmacogenomics and observing markers. Albeit various difficulties should be met to make customized drug a reality, with time, this methodology will supplant the conventional experimentation routine of medication.

Customized way of life prescription is a recently created term that alludes to a way to deal with medication in which an individual's wellbeing measurements from purpose of-consideration diagnostics are utilized to create way of life drug situated remedial systems for enhancing singular wellbeing results in overseeing incessant infection. Customized way of life pharmaceutical can give answers for incessant harnessing so as to wellbeing issues imaginative and advancing advances in view of late disclosures in genomics, epigenetics, frameworks science, life and behavioral sciences, and diagnostics and clinical solution.

Market Analysis

The Euro market estimation for customized drugs is anticipated to develop at the exacerbated yearly development rate of 7.5% amid 2009 to 2015. This development in future is required to be driven by various elements such as cost investment funds on medicines, early conclusion of ailment, medication wellbeing, quiet consistence, and improvement of treatments. Right now, America commands the business sector for customized pharmaceutical; be that as it may, progression in innovation and advancements in the field of DNA is required to set up Personalized Medicine Market in USA, UK, France, India, China, and Japan.

Quick advances in innovation have made it attainable to recognize a man's one of a kind genome. One individual varies from another by a large number of varieties in the genome, and a considerable lot of these varieties influence weakness to infection and reaction to medications. More noteworthy comprehension of individual genomes is permitting researchers and clinicians to start to "customize" medication. The Personalized Genomic Medicine insurgency will yield more viable medications with less unfavorable reactions and lead to longer, more beneficial lives and lower human services costs. The customized pharmaceutical industry in the United States as of now produces $286 billion every year in incomes and is developing by 11% every year, as indicated by Price water house Coopers Research at JAX Genomic Medicine will add to customized solution by uncovering how genomic varieties influence wellbeing, malady and medication reaction.

The worldwide Personalized Medicine Industry was esteemed at 8,956.14 billion EUR in 2014 and is relied upon to achieve 2179.32 billion EUR in 2022, developing at a CAGR of 11.8% over the gauge period. Key drivers of the business sector incorporate developing improvement of cutting edge sequencing, entire genome innovation, partner diagnostics and developing number of retail facilities.









Past Conference Report

Personalized Medicine 2016

The 4th International conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics, hosted by Conference series LLC was successfully held during September 22-23, 2016 at  Phoenix, USA. The conference highlighted the theme Emphasizing the Knowledge of Personalized Medicine. The conference was successful in gathering eminent speakers from various reputed organizations and their paramount talks enlightened the gathering.

The pragmatic meet organized by CONFERENCE SERIES LLC received generous response from the Editorial Board Members of CONFERENCE SERIES LLC Journals as well as expertise from academia, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2016 from CONFERENCE SERIES LLC. The conference was marked with the presence of renowned Speakers, Young Researchers, Students and Business Delegates driving the two day event into the path of success with thought provoking keynote and plenary presentations.

The highlights of the meeting were the keynote lectures from

  • Howard R. Moskowitz, Mind Genomics Associates, USA
  • Ramon Cacabelos, EuroEspes Biomedical Research Center, Spain
  • Sean Xinghua Hu,Global Data, USA
  • Sergey Suchkov, I.M.Sechenov First Moscow State Medical University, Russia
  • David Duggan,Translational Genomics Research Institute, USA

All the above mentioned Honourable Guests and Keynote speakers gave their energetic and fruitful contributions and special thanks to our Moderator Dr. Gargi Basu, Ashion Analytics, USA for her remarkable contribution towards smooth functioning at Personalized medicine 2016. The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Personalized medicine: Paths Of Biomarkers | Clinical Case Reports | Lifestyle Medicine | Preventive Medicines | Personalized Medicine & its Innovations | Personalized oncology | Immunology infectious disease | Cardiology and vascular medicine | Approaches To Stem Cells | Genetics Of Ebola Outbreak | Genomics & Personalized Medicine | Pharmacogenomics: Convergence of Pharmacology & Genomics | Market Strategies & Challenges In Personalised Medicine

CONFERENCE SERIES LLC would like to convey a warm gratitude to all Honourable Guests and Keynote Speakers of Personalized Medicine 2016 Conference.

Personalized Medicine 2016 Conference witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of personalized medicine. The event enlightened various arenas of genomics in different fields with plenary lectures from the speakers of various universities and organizations like

  • Howard R. Moskowitz, Mind Genomics Associates, USA
  • David Duggan, Imaging Endpoints, USA
  • Sean X Hu, Global Data, USA
  • Sergey Suchkov, I.M.Sechenov First Moscow State Medical University, Moscow, Russia
  • Vincent S. Gallicchio, Clemson University, USA 
  • Bahram G Kermani, Crystal Genetics Inc., USA
  • Gregory Fiore, Fiore Healthcare Advisors, USA
  • Anthony Johnson, Empire Genomics LLC, USA
  • Hiroyuki A Watanabe, Kohnan Aozora, Japan
  • Gargi Basu, Ashion Analytics, USA

We are obliged to various delegate experts, institutes and other eminent personalities who actively took part in the discussion and meetings. We sincerely thank the Organizing Committee Members for their gracious presence and continuous support towards the success of Personalized Medicine 2016 Conference.

With the valuable feedback and generous response received from the participants of the event, CONFERENCE SERIES LLC would like to announce the commencement of the 7th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics Oct 23-25, 2017 Chicago, USA

Personalized Medicine 2016 Conference Proceedings

Let us meet again @ Personalized Medicine 2017

 


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date Oct 23-25, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations